FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:190 January 19, 1995 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: In Dr. Pope's thoughtful review of acid-reflux disorders (Sept. 8 issue),¹ endoscopy is considered to be indicated only in a patient who continues to have symptoms after antireflux treatment. Assuming that the purpose of endoscopy is to evaluate the degree of esophagitis and, possibly of greater importance, to rule out the presence of Barrett's esophagus, one could make a strong argument that patients who have a response to antireflux therapy are particularly good candidates for endoscopy. Because the metaplastic tissue in the distal esophagus in Barrett's syndrome can resemble gastric mucosal lining, there may be less sensitivity . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Nordenvall, C, Nyren, O, Ye, W (2006). Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions. Gut 55: 703-707 [Abstract] [Full Text]